Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dolastatin-10 in Recurrent/Metastatic Sarcoma
NCT00003778Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 1999
- Primary completion
- Jul 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dolastatin 10 in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Apr 1999; status: completed.
02
Drugs
dolastatin 10
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00003778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003778.